|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
1 months to Jan 19, 2023
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|---|---|
| Profit (loss) | |||||
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustment to reconcile net loss used in operating activities: | |||||
| Loss from discontinued operations | |||||
| (Gain) Loss from discontinued operations | |||||
| Gain from discontinued operations | |||||
| Depreciation and amortization | |||||
| Other loss | |||||
| Share-based compensation | |||||
| Bad debt expense | |||||
| Impairment loss | |||||
| Gain on debt extinguishment | |||||
| Changes in operating assets and liabilities: | |||||
| Other current assets | |||||
| Prepaid expenses and other current assets | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Accounts payable and accrued liabilities | |||||
| Advances from customers | |||||
| Net cash used in operating activities from continuing operations | |||||
| Net cash provided by operating activities from discontinued operations | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Acquisition of intangible assets | |||||
| Net cash used in investing activities | |||||
| Proceeds from third parties | |||||
| Repayments to third parties | |||||
| Advance from related party | |||||
| Proceeds from a shareholder’s loan | |||||
| Repayment to a shareholder | |||||
| Proceeds from a shareholder | |||||
| Repayment to shareholder | |||||
| Proceeds from issuance of common stock | |||||
| Net cash provided by financing activities | |||||
| CASH AT BEGINNING OF YEAR | |||||
| CASH AT END OF YEAR | |||||
| Effect of exchange rate changes in cash and cash equivalents | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning balance | |||||
| Less: cash and cash equivalents, ending balance from discontinued operations | |||||
| Cash and cash equivalents, ending balance | |||||
| Supplemental Disclosures of Non-Cash Investing and Financing Activities | |||||
| Acquisition of intangible assets settled by accrued liabilities | |||||
| Repayment of commercial loan by related party on behalf of the Company | |||||
| Common stocks issued for debt settlement | |||||
| Common stock issued for debt settlement | |||||
| Litigation settlement via foreclosure of property | |||||
| Property write-off for litigation due to foreclosure of property | |||||
Loading...